Clinical Trial Update: Evaluation of Initiation Time on the Efficacy of Gabapentin in Treating Neuropathic Pain in SCI [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how initiation time affects gabapentin efficacy for neuropathic pain in spinal cord injury was completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: MetroHealth Medical Center | Conditions: Spinal Cord Injuries, Neuropathic Pain | Phase 4 | Status: COMPLETED | Results posted: 2021-11-15